Tag: Formulations business

Biocon Group CEO Peter Bains Anticipates Formulations Business to Surpass API Business

Biocon, a leading player in the biosimilar market, is set to make significant strides in the upcoming financial year of 2024-25 (FY25). Peter Bains, the group chief executive officer of Biocon, sheds light on the company’s strategies and outlook in a recent video interview with Aneeka Chatterjee. One of the key areas of focus for […]

Back To Top